BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7627511)

  • 41. [Vascularization of fibroadenomas: contrast harmonic imaging compared with contrast-enhanced power doppler].
    Huber S; Stiskal M; Steinbach R; Czembirek H
    Rofo; 2000 Oct; 172(10):830-5. PubMed ID: 11111295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristic imaging features of breast fibroadenomas in women given cyclosporin A after renal transplantation.
    Son EJ; Oh KK; Kim EK; Cho N; Lee JD; Kim SH; Jung WH
    J Clin Ultrasound; 2004 Feb; 32(2):69-77. PubMed ID: 14750137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and pathologic features of fibroadenoma of the mastopathic type.
    Kuroda H; Takeuchi I; Ohnishi K; Sakamoto G; Akiyama F; Toyozumi Y; Momose S; Tamaru J; Itoyama S
    Surg Today; 2006; 36(7):590-5. PubMed ID: 16794792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results.
    Jung EM; Jungius KP; Rupp N; Gallegos M; Ritter G; Lenhart M; Clevert DA; Kubale R
    Clin Hemorheol Microcirc; 2005; 33(2):109-20. PubMed ID: 16151258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroadenomas: a multidisciplinary review of the variants.
    Basara Akin I; Balci P
    Clin Imaging; 2021 Mar; 71():83-100. PubMed ID: 33186871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation of benign and malignant breast tumors using Doppler spectral parameters including acceleration time index.
    Mesaki K; Hisa N; Kubota K; Hisa N; Ogawa Y; Yoshida S
    Oncol Rep; 2003; 10(4):945-50. PubMed ID: 12792750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical office-based ultrasound of the breast.
    Staren ED
    Am Surg; 1995 Jul; 61(7):619-26; discussion 627. PubMed ID: 7793744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer.
    Franco N; Arnould L; Mege F; Picard SF; Arveux P; Lizard-Nacol S
    Arch Surg; 2003 Mar; 138(3):291-5. PubMed ID: 12611577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Power Doppler sonography of breast cancer: does vascularity correlate with node status or lymphatic vascular invasion?
    Mehta TS; Raza S
    AJR Am J Roentgenol; 1999 Aug; 173(2):303-7. PubMed ID: 10430124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Alterations in blood flow as a diagnostic criteria for breast cancer].
    Fisenko EP
    Angiol Sosud Khir; 2009; 15(1):33-8. PubMed ID: 19791573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes.
    Yang WT; Chang J; Metreweli C
    Radiology; 2000 May; 215(2):568-73. PubMed ID: 10796941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of benign versus malignant breast disease.
    Ellis RL
    Radiology; 1999 Mar; 210(3):878-80. PubMed ID: 10207498
    [No Abstract]   [Full Text] [Related]  

  • 53. Power Doppler sonography: evaluation of solid breast lesions and correlation with lymph node metastasis.
    Kwak JY; Kim EK; Kim MJ; Choi SH; Son E; Oh KK
    Clin Imaging; 2008; 32(3):167-71. PubMed ID: 18502342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of fibroadenoma of the breast.
    Carty NJ; Carter C; Rubin C; Ravichandran D; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1995 Mar; 77(2):127-30. PubMed ID: 7793802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can ultrasound be used to differentiate tubular adenomas of breast from fibroadenomas or carcinoma?
    Fu Y; Miao LY; Ge HY; Mei F; Wang JR
    Asian Pac J Cancer Prev; 2014; 15(3):1269-74. PubMed ID: 24606451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sonographic appearances of juvenile fibroadenoma of the breast.
    Kim SJ; Park YM; Jung SJ; Lee KH; Kim OH; Ryu JH; Choi GB; Lee SJ; Choo HJ; Jeong HW
    J Ultrasound Med; 2014 Nov; 33(11):1879-84. PubMed ID: 25336474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy.
    Sperber F; Blank A; Metser U; Flusser G; Klausner JM; Lev-Chelouche D
    Arch Surg; 2003 Jul; 138(7):796-800. PubMed ID: 12860764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Office-based cryoablation of breast fibroadenomas: 12-month followup.
    Kaufman CS; Littrup PJ; Freman-Gibb LA; Francescatti D; Stocks LH; Smith JS; Henry CA; Bailey L; Harness JK; Simmons R
    J Am Coll Surg; 2004 Jun; 198(6):914-23. PubMed ID: 15194073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome of benign fibroadenomas treated by ultrasound-guided percutaneous excision.
    Grady I; Gorsuch H; Wilburn-Bailey S
    Breast J; 2008; 14(3):275-8. PubMed ID: 18397185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-time high resolution ultrasonography of solid breast masses: use of a 10-MHz mechanical sector transducer with a water bag.
    Saitoh R; Kojima R; Ito K; Saitoh Y; Tsuchigame T; Takahashi M
    Radiat Med; 1994; 12(5):201-8. PubMed ID: 7863023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.